Regulation of mycobacterium-specific mononuclear cell responses by 25-hydroxyvitamin d3

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Nelson, Corwin D ^a,b,c   Nonnecke, Brian J ^a   Reinhardt, Timothy A ^a   Waters, W Ray ^a   Beitz, Donald C ^b   Lippolis, John D ^a  

^a NATIONAL ANIMAL DISEASE CENTER   (United States)

^b IOWA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CALCIFEDIOL; CALCITRIOL; CD14 ANTIGEN; CD3 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 17F; OXYGENASE; CALCIDIOL 1 MONOOXYGENASE; NITRIC OXIDE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CALF (BOVINE); CALF (MAMMAL); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; GENE SEQUENCE; INNATE IMMUNITY; MALE; MONOCYTE; MYCOBACTERIUM BOVIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; T LYMPHOCYTE; VACCINATION; ANIMAL; CATTLE; CELL CULTURE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL;

ANIMALIA; BOS; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ANIMALS; CALCIFEDIOL; CATTLE; CELLS, CULTURED; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MYCOBACTERIUM BOVIS; NITRIC OXIDE;

EID: 79959622526     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0021674     Document Type: Article

References (79)

1. Adams JS, Hewison M, (2010) Update in vitamin d. J Clin Endocrinol Metab 95: 471-478.
2. Ginde AA, Mansbach JM, Camargo CA Jr, (2009) Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 169: 384-390.
3. Nnoaham KE, Clarke A, (2008) Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 37: 113-119.
4. Williams B, Williams AJ, Anderson ST, (2008) Vitamin D deficiency and insufficiency in children with tuberculosis. Pediatr Infect Dis J 27: 941-942.
5. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A, (2006) Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Jama 296: 2832-2838.
6. Munger KL, Zhang SM, O'Reilly E, Hernan MA, Olek MJ, et al. (2004) Vitamin D intake and incidence of multiple sclerosis. Neurology 62: 60-65.
7. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, et al. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr.
8. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, et al. (2010) A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74: 1852-1859.
9. Martineau AR, Wilkinson RJ, Wilkinson KA, Newton SM, Kampmann B, et al. (2007) A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir Crit Care Med 176: 208-213.
10. Hewison M, (2010) Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol 321: 103-111.
11. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC, (1983) 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221: 1181-1183.
12. Veldman CM, Cantorna MT, DeLuca HF, (2000) Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374: 334-338.
13. Reinhardt TA, Horst RL, Littledike ET, Beitz DC, (1982) 1,25-Dihydroxyvitamin D3 receptor in bovine thymus gland. Biochem Biophys Res Commun 106: 1012-1018.
14. Koszewski NJ, Reinhardt TA, Horst RL, (1996) Vitamin D receptor interactions with the murine osteopontin response element. J Steroid Biochem Mol Biol 59: 377-388.
15. Pike JW, Meyer MB, Watanuki M, Kim S, Zella LA, et al. (2007) Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptor. J Steroid Biochem Mol Biol 103: 389-395.
16. Gombart AF, Borregaard N, Koeffler HP, (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB Journal 19: 1067-1077.
17. Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, et al. (2009) Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 4: e5810.
18. Wang TT, Nestel FP, Bourdeau V, Naga iY, Wang Q, et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. Journal of Immunology 173: 2909-2912.
19. Wang TT, Dabbas B, Laperriere D, Bitton AJ, Soualhine H, et al. (2010) Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin beta2 innate immune pathway defective in Crohn disease. J Biol Chem 285: 2227-2231.
20. Nelson CD, Reinhardt TA, Thacker TC, Beitz DC, Lippolis JD, (2010) Modulation of the bovine innate immune response by production of 1alpha,25-dihydroxyvitamin D(3) in bovine monocytes. J Dairy Sci 93: 1041-1049.
21. Koizumi T, Nakao Y, Matsui T, Nakagawa T, Katakami Y, et al. (1985) Effect of 1,25-dihydroxyvitamin D3 on cytokine-induced thymocyte proliferation. Cell Immunol 96: 455-461.
22. Lemire JM, Adams JS, Sakai R, Jordan SC, (1984) 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 74: 657-661.
23. Muller K, Bendtzen K, (1992) Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity 14: 37-43.
24. Nonnecke BJ, Franklin ST, Reinhardt TA, Horst RL, (1993) In vitro modulation of proliferation and phenotype of resting and mitogen-stimulated bovine mononuclear leukocytes by 1,25-dihydroxyvitamin D3. Vet Immunol Immunopathol 38: 75-89.
25. Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, et al. (2009) 1,25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol 183: 5458-5467.
26. Lemire JM, (1995) Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 53: 599-602.
27. Staeva-Vieira TP, Freedman LP, (2002) 1,25-dihydroxyvitamin D3 inhibits IFN-gamma and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168: 1181-1189.
28. Reichel H, Koeffler HP, Tobler A, Norman AW, (1987) 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci U S A 84: 3385-3389.
29. Waters WR, Nonnecke BJ, Rahner TE, Palmer MV, Whipple DL, et al. (2001) Modulation of Mycobacterium bovis-specific responses of bovine peripheral blood mononuclear cells by 1,25-dihydroxyvitamin D(3). Clin Diagn Lab Immunol 8: 1204-1212.
30. Chang JH, Cha HR, Lee DS, Seo KY, Kweon MN, (2010) 1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis. PLoS One 5: e12925.
31. Palmer MT, Lee YK, Maynard CL, Oliver JR, Bikle DD, et al. (2011) Lineage-specific effects of 1,25-dihydroxyvitamin D(3) on the development of effector CD4 T cells. J Biol Chem 286: 997-1004.
32. Cantorna MT, Hayes CE, DeLuca HF, (1996) 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc Natl Acad Sci U S A 93: 7861-7864.
33. Lemire JM, Archer DC, (1991) 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J Clin Invest 87: 1103-1107.
34. Tang J, Zhou R, Luger D, Zhu W, Silver PB, et al. (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182: 4624-4632.
35. Mayne CG, Spanier JA, Relland LM, Williams CB, Hayes CE, (2011) 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis. European Journal of Immunology In press.
36. Sakaki T, Kagawa N, Yamamoto K, Inouye K, (2005) Metabolism of vitamin D3 by cytochromes P450. Front Biosci 10: 119-134.
37. Horst RL, Goff JP, Reinhardt TA, (2003) Role of vitamin D in calcium homeostasis and its use in prevention of bovine periparturient paresis. Acta Vet Scand Suppl 97: 35-50.
38. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, et al. (2009) Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182: 4289-4295.
39. Smolders J, Menheere P, Thewissen M, Peelen E, Cohen Tervaert JW, et al. (2010) Regulatory T cell function correlates with serum 25-hydroxyvitamin D, but not with 1,25-dihydroxyvitamin D, parathyroid hormone and calcium levels in patients with relapsing remitting multiple sclerosis. J Steroid Biochem Mol Biol 121: 243-246.
40. Waldron MR, Nonnecke BJ, Nishida T, Horst RL, Overton TR, (2003) Effect of lipopolysaccharide infusion on serum macromineral and vitamin D concentrations in dairy cows. J Dairy Sci 86: 3440-3446.
41. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, et al. (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311: 1770-1773.
42. Stoffels K, Overbergh L, Bouillon R, Mathieu C, (2007) Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway. J Steroid Biochem Mol Biol 103: 567-571.
43. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE, (2007) Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179: 1634-1647.
44. Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, et al. (2007) DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8: 285-293.
45. Nelson CD, Reinhardt TA, Beitz DC, Lippolis JD, (2010) In vivo activation of the intracrine vitamin d pathway in innate immune cells and mammary tissue during a bacterial infection. PLoS One 5: e15469.
46. Rhodes SG, Terry LA, Hope J, Hewinson RG, Vordermeier HM, (2003) 1,25-dihydroxyvitamin D3 and development of tuberculosis in cattle. Clin Diagn Lab Immunol 10: 1129-1135.
47. Spach KM, Hayes CE, (2005) Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J Immunol 175: 4119-4126.
48. Hewison M, (2010) Vitamin D and the intracrinology of innate immunity. Mol Cell Endocrinol DOI:10.1016/j.mce.2010.02.013.
49. Vordermeier HM, Villarreal-Ramos B, Cockle PJ, McAulay M, Rhodes SG, et al. (2009) Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis. Infect Immun 77: 3364-3373.
50. Endsley JJ, Waters WR, Palmer MV, Nonnecke BJ, Thacker TC, et al. (2009) The calf model of immunity for development of a vaccine against tuberculosis. Vet Immunol Immunopathol 128: 199-204.
51. Van Rhijn I, Godfroid J, Michel A, Rutten V, (2008) Bovine tuberculosis as a model for human tuberculosis: advantages over small animal models. Microbes Infect 10: 711-715.
52. Hollis BW, (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135: 317-322.
53. Horst RL, Goff JP, Reinhardt TA, (2005) Adapting to the transition between gestation and lactation: differences between rat, human and dairy cow. J Mammary Gland Biol Neoplasia 10: 141-156.
54. Nonnecke BJ, Foote MR, Miller BL, Beitz DC, Horst RL, (2010) Short communication: Fat-soluble vitamin and mineral status of milk replacer-fed dairy calves: effect of growth rate during the preruminant period. J Dairy Sci 93: 2684-2690.
55. Heaney RP, (2008) Vitamin D: criteria for safety and efficacy. Nutr Rev 66: S178-181.
56. Horst RL, Goff JP, Reinhardt TA, (1994) Calcium and vitamin D metabolism in the dairy cow. J Dairy Sci 77: 1936-1951.
57. Foote MR, Nonnecke BJ, Beitz DC, Waters WR, (2007) Antigen-specific B-cell responses by neonatal calves after early vaccination. J Dairy Sci 90: 5208-5217.
58. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
59. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
60. Lemire JM, Adams JS, Kermani-Arab V, Bakke AC, Sakai R, et al. (1985) 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro. J Immunol 134: 3032-3035.
61. Nashold FE, Hoag KA, Goverman J, Hayes CE, (2001) Rag-1-dependent cells are necessary for 1,25-dihydroxyvitamin D(3) prevention of experimental autoimmune encephalomyelitis. J Neuroimmunol 119: 16-29.
62. Pedersen LB, Nashold FE, Spach KM, Hayes CE, (2007) 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 85: 2480-2490.
63. Stoffels K, Overbergh L, Giulietti A, Verlinden L, Bouillon R, et al. (2006) Immune regulation of 25-hydroxyvitamin-D3-1-hydroxylase in human monocytes. Journal of Bone and Mineral Research 21: 37-47.
64. Baeke F, Korf H, Overbergh L, van Etten E, Verstuyf A, et al. (2010) Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D(3) in the immune system. J Steroid Biochem Mol Biol.
65. Hu X, Ivashkiv LB, (2009) Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31: 539-550.
66. Cooper AM, (2009) T cells in mycobacterial infection and disease. Curr Opin Immunol 21: 378-384.
67. de Almeida DE, Colvin CJ, Coussens PM, (2008) Antigen-specific regulatory T cells in bovine paratuberculosis. Vet Immunol Immunopathol 125: 234-245.
68. Dong C, (2008) Regulation and pro-inflammatory function of interleukin-17 family cytokines. Immunol Rev 226: 80-86.
69. Curtis MM, Way SS, (2009) Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology 126: 177-185.
70. Peck A, Mellins ED, (2010) Precarious balance: Th17 cells in host defense. Infect Immun 78: 32-38.
71. Dittel BN, (2008) CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain Behav Immun 22: 421-430.
72. Cantorna MT, (2010) Mechanisms underlying the effect of vitamin D on the immune system. Proc Nutr Soc 69: 286-289.
73. Bogdan C, (2011) Regulation of lymphocytes by nitric oxide. Methods Mol Biol 677: 375-393.
74. Levy JA, (2009) The unexpected pleiotropic activities of RANTES. J Immunol 182: 3945-3946.
75. Widdison S, Watson M, Piercy J, Howard C, Coffey TJ, (2008) Granulocyte chemotactic properties of M. tuberculosis versus M. bovis-infected bovine alveolar macrophages. Mol Immunol 45: 740-749.
76. Holick MF, (2008) Sunlight, UV-radiation, vitamin D and skin cancer: how much sunlight do we need? Adv Exp Med Biol 624: 1-15.
77. NRC (2001) Nutrient Requirements of Dairy Cattle: Seventh Revised Edition Washington, DC Natl Acad Sci.
78. Vieth R, (2007) Vitamin D toxicity, policy, and science. J Bone Miner Res 22 (Suppl 2): V64-68.
79. Hollis BW, (2009) Nutrition: US recommendations fail to correct vitamin D deficiency. Nat Rev Endocrinol 5: 534-536.